Therapy assessment in prostate cancer using choline and PSMA PET/CT
- PMID: 28540419
- DOI: 10.1007/s00259-017-3723-3
Therapy assessment in prostate cancer using choline and PSMA PET/CT
Abstract
While PET with non-FDG tracers (mainly choline and Ga-PSMA) has commonly been used for restaging in men with biochemically recurrent prostate cancer, as well as for primary staging, it is only recently that a few preliminary studies have addressed the possible use of PET for monitoring the response to systemic therapy of metastatic disease, especially innovative treatments such as abiraterone and enzalutamide. This article aims to evaluate the role of PET imaging with different non-FDG radiotracers for assessment of therapy in advanced prostate cancer patients.
Keywords: Choline; PSMA; Pet/Ct; Prostate cancer; Therapy assessment; mCRPC.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous